BR9916726A - HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes - Google Patents

HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes

Info

Publication number
BR9916726A
BR9916726A BR9916726-3A BR9916726A BR9916726A BR 9916726 A BR9916726 A BR 9916726A BR 9916726 A BR9916726 A BR 9916726A BR 9916726 A BR9916726 A BR 9916726A
Authority
BR
Brazil
Prior art keywords
mobilization
growth hormone
human growth
stimulate
stem cells
Prior art date
Application number
BR9916726-3A
Other languages
English (en)
Inventor
Alessandro Massimo Gianni
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR9916726A publication Critical patent/BR9916726A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Patente de Invenção: <B>"HORMÈNIO DO CRESCIMENTO HUMANO PARA ESTIMULAR A MOBILIZAçãO DE CéLULAS TRONCO HEMATOPOIéTICAS PLURIPOTENTES"<D>. A presente invenção está relacionada ao campo da mobilização hematopoiética da célula CD34+. Em particular, a presente invenção refere-se a um método para aumentar a mobilização de células CD34+ hematopoiéticas pluripotentes, mediante administração do hormónio do crescimento ou um de seus derivados a um indivíduo.
BR9916726-3A 1998-12-30 1999-12-30 HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes BR9916726A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
BR9916726A true BR9916726A (pt) 2001-09-11

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916726-3A BR9916726A (pt) 1998-12-30 1999-12-30 HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes

Country Status (15)

Country Link
US (1) US20060029581A1 (pt)
EP (3) EP1016413A1 (pt)
JP (1) JP4808316B2 (pt)
AT (1) ATE342064T1 (pt)
AU (2) AU772222B2 (pt)
BR (1) BR9916726A (pt)
CA (1) CA2354194A1 (pt)
CY (1) CY1107603T1 (pt)
DE (1) DE69933581T2 (pt)
DK (1) DK1140149T3 (pt)
ES (1) ES2275359T3 (pt)
IL (2) IL143994A0 (pt)
PT (1) PT1140149E (pt)
SI (1) SI1140149T1 (pt)
WO (1) WO2000040260A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535144A (ja) * 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
EP1315835A2 (en) 2000-08-01 2003-06-04 Yissum Research Development Company of the Hebrew University of Jerusalem Directed differentiation of embryonic cells
EP1411918B1 (en) 2001-07-31 2011-12-28 Genzyme Global S.à.r.l. Methods to mobilize progenitor/stem cells
CA2540529C (en) 2003-10-03 2012-03-13 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
US7816320B2 (en) * 2004-12-22 2010-10-19 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
NZ600363A (en) * 2009-12-21 2014-07-25 Ambrx Inc Modified porcine somatotropin polypeptides and their uses

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
ATE213952T1 (de) * 1993-06-15 2002-03-15 British Biotech Pharm Freisetzung und mobilisierung hämatopoietischer zellen
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
WO1995009912A1 (en) * 1993-10-06 1995-04-13 University Of Florida Research Foundation, Inc. Stem cell proliferation factor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
CA2227241C (en) * 1995-07-21 2004-12-21 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
DK1016414T3 (da) * 1998-12-17 2005-01-17 Applied Research Systems Humant væksthormon til stimulering af hæmatopoise og immunkonstitution efter transplantation med hæmatopoietiske stamceller i mennesker
JP2003535144A (ja) * 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
DE69933581T2 (de) 2007-06-21
CY1107603T1 (el) 2013-03-13
AU2004203355A1 (en) 2004-08-19
ES2275359T3 (es) 2007-06-01
SI1140149T1 (sl) 2007-02-28
AU772222B2 (en) 2004-04-22
IL143994A (en) 2009-06-15
EP1016413A1 (en) 2000-07-05
EP1140149A1 (en) 2001-10-10
DE69933581D1 (de) 2006-11-23
AU2004203355B2 (en) 2007-05-17
EP1779865A1 (en) 2007-05-02
JP4808316B2 (ja) 2011-11-02
US20060029581A1 (en) 2006-02-09
CA2354194A1 (en) 2000-07-13
PT1140149E (pt) 2007-01-31
WO2000040260A1 (en) 2000-07-13
JP2002534393A (ja) 2002-10-15
EP1140149B1 (en) 2006-10-11
DK1140149T3 (da) 2007-02-19
IL143994A0 (en) 2002-04-21
ATE342064T1 (de) 2006-11-15
AU2103900A (en) 2000-07-24

Similar Documents

Publication Publication Date Title
ATE514772T1 (de) Multipotente erwachsene stammzellen und verfahren zu deren isolierung
AR025683A1 (es) Composiciones de d-endotoxina de bacillus thuringiensis activas contra lepidopteros y metodos de uso
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
AR053383A2 (es) Celulas vegetales transformadas, plantas que las contienen y uso de una construccion de adn en un metodo
WO2003104443A3 (de) Mesenchymale stammzellen des haarfollikels und deren verwendung
ES2061720T3 (es) Transformacion de tejido vegetal.
WO2003004605A3 (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
WO2001021766A8 (en) Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
EP1471970A4 (en) NOVEL MULTIPOTENT STEM CELLS OF MAMMALIAN ORIGIN, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION OF SAID CELLS
AU2003285172A8 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
DOP2000000107A (es) Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas
ATE514771T1 (de) Haartransplantation
ATE492266T1 (de) Farbverändernde mittel mit moringa extrakt
DE60044655D1 (de) Angereicherte Zellpopulationen des zentralen Nervensystems
ES2196172T3 (es) Transplante neuronal utilizando celulas neuroepiteliales pluripotentes.
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
EP1295611A4 (en) COMPOUNDS FOR THE TRANSFER OF OLIGONUCLEOTIDES (03.01.02)
HUP0102293A2 (hu) Interleukin-6 termelődését serkentő vegyületet tartalmazó kozmetikai kompozíció
WO2005037219A3 (en) Disinfecting teat care compositions
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
BRPI0403200A (pt) Método para recrescimento de células embriogênicas crioconservadas de conìferas
WO2003062197A3 (en) Nek2 inhibitors

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13, 24, 25 E 10 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 38/27; C12N 5/06; C12N 5/08; A61K 35/14; A61K 35/28.

Ipc: A61K 38/27 (2006.01), A61K 35/00 (2006.01)

Ipc: A61K 38/27 (2006.01), A61K 35/00 (2006.01)